This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

By Members of the Research Division, S. B. Penick & Company. Price not given. Pp. 127, with 31 tables. S. B. Penick & Co., 50 Church Street, New York, 1952.

AMA Arch Intern Med. 1952;90(3):424.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This book is nothing more than an annotated bibliography on bacitracin. It contains a few statements that embrace generalities concerning antibiotic agents which are good. It is obviously a conspicuous effort to make bacitracin look better than it actually is from the standpoint of antibiotic therapy. The volume does not emphasize the nephrotoxic properties of bacitracin which seriously limit the use of this antibiotic in clinical medicine. On the contrary, the nephrotoxicity of this agent is deprecated, and efforts are made in certain portions of the book to explain nephrotoxicity on a basis other than that of the drug itself. Contrary to what is said in this work, bacitracin is hardly the drug of choice in the treatment of amebiasis. It certainly is of little or no value, despite the authors' contentions, in the treatment of ulcerative colitis and in the preoperative preparation of patients for operations on the bowel. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?